Polaris Capital Management LLC Purchases 115,500 Shares of CVS Health Corporation $CVS

Polaris Capital Management LLC raised its position in CVS Health Corporation (NYSE:CVS) by 23.7% in the third quarter, HoldingsChannel.com reports. The fund owned 602,600 shares of the pharmacy operator’s stock after purchasing an additional 115,500 shares during the quarter. CVS Health accounts for approximately 3.0% of Polaris Capital Management LLC’s portfolio, making the stock its 8th biggest holding. Polaris Capital Management LLC’s holdings in CVS Health were worth $45,430,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the company. Harbor Capital Advisors Inc. raised its stake in CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares in the last quarter. Avion Wealth increased its holdings in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the period. Corundum Trust Company INC acquired a new stake in shares of CVS Health in the third quarter valued at approximately $29,000. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health in the second quarter valued at approximately $30,000. Finally, Front Row Advisors LLC grew its position in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 371 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Wall Street Zen downgraded CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. The Goldman Sachs Group raised their target price on shares of CVS Health from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, December 10th. Raymond James Financial increased their price target on shares of CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st. Finally, Mizuho lifted their price objective on shares of CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $94.86.

CVS Health Stock Performance

NYSE CVS opened at $80.36 on Tuesday. The firm’s fifty day moving average price is $78.73 and its two-hundred day moving average price is $74.02. The stock has a market cap of $102.02 billion, a PE ratio of 211.49, a PEG ratio of 0.74 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health Corporation has a fifty-two week low of $49.52 and a fifty-two week high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same quarter in the previous year, the company posted $1.09 EPS. CVS Health’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s payout ratio is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.